S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

PNT POINT Biopharma Global Inc

12.50

0.00 (0.00%)

12 Nov 2024 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

POINT Biopharma Global (NASDAQ:PNT)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more POINT Biopharma Global Charts.

POINT Biopharma Global (NASDAQ:PNT)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more POINT Biopharma Global Charts.

POINT Biopharma Global Inc News

Form 15-12G - Securities registration termination [Section 12(g)]
Monday 8 January 2024 (10 months ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Wednesday 3 January 2024 (10 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 28 December 2023 (11 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 28 December 2023 (11 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 28 December 2023 (11 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 28 December 2023 (11 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 28 December 2023 (11 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 28 December 2023 (11 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 28 December 2023 (11 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 28 December 2023 (11 months ago) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Thursday 28 December 2023 (11 months ago) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Thursday 28 December 2023 (11 months ago) • Edgar (US Regulatory)

More POINT Biopharma Global Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions